MedTech Terms
    The authoritative reference
    All terms

    MS-DRG

    Medicare's inpatient hospital payment classification system.

    Reviewed by Christian Espinosa, Founder, Blue Goat CyberLast reviewed May 5, 2026

    Definition

    Medicare Severity Diagnosis-Related Groups classify inpatient stays into payment groups based on diagnosis, procedures, age, and complications. Each MS-DRG carries a relative weight; the hospital is paid a bundled rate regardless of actual cost.
    What the regulation says
    Medicare Severity-Diagnosis Related Groups (MS-DRGs) are a prospective payment system used by the Centers for Medicare & Medicaid Services (CMS) in the United States to reimburse hospitals for inpatient stays under Medicare Part A. This system is mandated by federal regulations, with details published annually in the Federal Register, outlining the classification logic and payment rates. The goal is to incentivize efficiency while ensuring appropriate payment for patient care, as described in CMS publications and guidelines.

    What this means in practice

    For inpatient device-based procedures, MS-DRG assignment determines whether the hospital is paid enough to cover the device cost. Inadequate MS-DRG mapping is a major commercial barrier; NTAP and new technology reassignment are remedies.

    Examples

    • A hospital performing a complex cardiac procedure with an innovative implantable device relies on the assigned MS-DRG to cover the costs of the device, staff, and other resources.
    • A MedTech company developing a new surgical robot must understand the potential MS-DRG classifications for procedures using its robot to predict adoption rates and financial viability for hospitals.
    • During an audit, CMS reviews a hospital's medical records to verify that the assigned MS-DRG accurately reflects the patient's condition and the medical services provided.
    Common pitfalls
    • Hospitals may inadvertently undercode or overcode, leading to incorrect reimbursement and potential audit scrutiny.
    • Device manufacturers might misunderstand how device costs are incorporated into MS-DRG payments, impacting market access strategies.
    • A lack of proper documentation for a device or procedure can lead to an unfavorable MS-DRG assignment.
    • Assuming that an innovative MedTech product will automatically receive adequate reimbursement without specific CMS pathways like NTAP is a common mistake.
    • Failing to consider the impact of MS-DRG assignment on post-market surveillance costs or potential recalls can lead to financial strain.

    Frequently asked questions

    MS-DRG assignment directly influences hospital reimbursement for procedures involving medical devices. If the assigned MS-DRG payment does not adequately cover the device cost, hospitals may be hesitant to adopt the technology, creating a market access barrier for device manufacturers.
    Grouped by theme

    Primary references

    3 sources
    Link health: 3 verified· last checked 2026-06-20
    CMS·1AMA·1AdvaMed·1
    1. 1
      CMS MS-DRG
      Verified
      CMScms.gov
    2. 2
      AMA CPT Resources
      Verified
      AMAama-assn.org
    3. 3
      AdvaMed - Payment & Coverage
      Verified
      AdvaMedadvamed.org

    Inline markers like [1] jump to the matching reference above.